Drug profile · INN
triclofos sodium
TRICLOS
triclofos sodium (TRICLOS) is a gaba-a receptor; anion channel positive modulator. Route of administration: oral. Current US regulatory status: approved.
Drug details — triclofos sodium
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
triclofos sodium (TRICLOS) is a gaba-a receptor; anion channel positive modulator. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
GABA-A receptor; anion channel positive modulator
Primary target: GABA-A receptor; anion channel
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is triclofos sodium?
triclofos sodium (TRICLOS) is a gaba-a receptor; anion channel positive modulator. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for triclofos sodium?
TRICLOS is a marketed brand name for triclofos sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of triclofos sodium?
triclofos sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.